Company: MVIS
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000783
Chunk: 42

Company: MICROVISION, INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 1A
Chunk 42
---
    Commitments and contingencies (Note 11) 
     -  
     - 

    Shareholders’ equity 

    Preferred stock, par value $0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of December 31, 2024 and 2023 
     -  
     - 
  
    Common stock, par value $0.001; 310,000 shares authorized; 224,993 and 194,736 shares issued and
    outstanding as of December 31, 2024 and 2023, respectively 
     225  
     195 
  
    Additional paid-in capital 
     910,825  
     860,765 
  
    Accumulated other comprehensive income 
     -  
     210 
  
    Accumulated deficit 
     (862,281) 
     (765,366)
  
    Total shareholders’ equity 
     48,769  
     95,804 
  
    Total liabilities and shareholders’ equity 
    $121,161  
    $129,635 

The
accompanying notes are an integral part of these consolidated financial statements

34

MicroVision,
Inc.

Consolidated
Statements of Operations

(In
thousands, except per share data)

    2024  
    2023  
    2022 

    Year Ended December 31, 

    2024  
    2023  
    2022 

    Revenue 
    $4,696  
    $7,259  
    $664 

    Cost of revenue 
     7,530  
     2,772  
     100 

    Gross (loss) profit 
     (2,834) 
     4,487  
     564 

    Research and development expense 
     49,015  
     56,707  
     30,413 
  
    Sales, marketing, general and administrative expense 
     29,346  
     36,689  
     24,041 
  
    Impairment loss on intangible assets 
     4,181  
     -  
     - 
  
    Loss (gain) on disposal of fixed assets 
     143  
     (34) 
     - 
  
    Total operating expenses